<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar2077</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Research article</dochead>
      <bibl>
         <title>
            <p>T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NF&#954;B: implications for rheumatoid arthritis</p>
         </title>
         <aug>
            <au id="A1" ca="yes" ce="yes">
               <snm>Beech</snm>
               <mi>T</mi>
               <fnm>Jonathan</fnm>
               <insr iid="I1"/>
               <email>j.beech@ic.ac.uk</email>
            </au>
            <au id="A2" ce="yes">
               <snm>Andreakos</snm>
               <fnm>Evangelos</fnm>
               <insr iid="I2"/>
               <email>vandreakos@bioacademy.gr</email>
            </au>
            <au id="A3">
               <snm>Ciesielski</snm>
               <mi>J</mi>
               <fnm>Cathleen</fnm>
               <insr iid="I1"/>
               <email>coast2coastgirl04@yahoo.com</email>
            </au>
            <au id="A4">
               <snm>Green</snm>
               <fnm>Patricia</fnm>
               <insr iid="I1"/>
               <email>patricia.green@imperial.ac.uk</email>
            </au>
            <au id="A5">
               <snm>Foxwell</snm>
               <mi>MJ</mi>
               <fnm>Brian</fnm>
               <insr iid="I1"/>
               <email>b.foxwell@imperial.ac.uk</email>
            </au>
            <au id="A6">
               <snm>Brennan</snm>
               <mi>M</mi>
               <fnm>Fionula</fnm>
               <insr iid="I1"/>
               <email>f.brennan@imperial.ac.uk</email>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK</p>
            </ins>
            <ins id="I2">
               <p>Foundation for Biomedical Research of the Academy of Athens, Center for Immunology and Transplantations, 4 Soranou tou Ephessiou, 11527 Athens, Greece</p>
            </ins>
         </insg>
         <source>Arthritis Research &amp; Therapy</source>
         <issn>1478-6354</issn>
         <pubdate>2006</pubdate>
         <volume>8</volume>
         <issue>6</issue>
         <fpage>R168</fpage>
         <url>http://arthritis-research.com/content/8/6/R168</url>
         <xrefbib>
            <pubidlist>
               <pubid idtype="pmpid">17101049</pubid>
               <pubid idtype="doi">10.1186/ar2077</pubid>
            </pubidlist>
         </xrefbib>
      </bibl>
      <history>
         <rec>
            <date>
               <day>07</day>
               <month>6</month>
               <year>2006</year>
            </date>
         </rec>
         <revreq>
            <date>
               <day>28</day>
               <month>6</month>
               <year>2006</year>
            </date>
         </revreq>
         <revrec>
            <date>
               <day>28</day>
               <month>9</month>
               <year>2006</year>
            </date>
         </revrec>
         <acc>
            <date>
               <day>13</day>
               <month>11</month>
               <year>2006</year>
            </date>
         </acc>
         <pub>
            <date>
               <day>13</day>
               <month>11</month>
               <year>2006</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2006</year>
         <collab>Beech et al.; licensee BioMed Central Ltd.</collab>
         <note>This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note>
      </cpyrt>
      <abs>
         <sec>
            <st>
               <p>Abstract</p>
            </st>
            <p>We and others have reported that rheumatoid arthritis (RA) synovial T cells can activate human monocytes/macrophages in a contact-dependent manner to induce the expression of inflammatory cytokines, including tumour necrosis factor alpha (TNF&#945;). In the present study we demonstrate that RA synovial T cells without further activation can also induce monocyte CC and CXC chemokine production in a contact-dependent manner. The transcription factor NF&#954;B is differentially involved in this process as CXC chemokines but not CC chemokines are inhibited after overexpression of I&#954;B&#945;, the natural inhibitor of NF&#954;B. This effector function of RA synovial T cells is also shared by T cells activated with a cytokine cocktail containing IL-2, IL-6 and TNF&#945;, but not T cells activated by anti-CD3 cross-linking that mimics TCR engagement. This study demonstrates for the first time that RA synovial T cells as well as cytokine-activated T cells are able to induce monocyte chemokine production in a contact-dependent manner and through NF&#954;B-dependent and NF&#954;B-independent mechanisms, in a process influenced by the phosphatidyl-inositol-3-kinase pathway. Moreover, this study provides further evidence that cytokine-activated T cells share aspects of their effector function with RA synovial T cells and that their targeting in the clinic has therapeutic potential.</p>
         </sec>
      </abs>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Introduction</p>
         </st>
         <p>A large and diverse range of proinflammatory cytokines and chemokines have been detected in the synovium of patients with rheumatoid arthritis (RA) (reviewed in <abbrgrp><abbr bid="B1">1</abbr><abbr bid="B2">2</abbr></abbrgrp>). This diversity is not surprising, considering the heterogeneous mixture of activated cells found at the sites of inflammation of RA synovium, which include macrophages, T cells, endothelial cells, fibroblasts and plasma cells.</p>
         <p>Of particular interest are chemokines, which selectively recruit haemopoietic cells from the blood into the inflamed synovium. Several chemokines have been detected in RA synovium and include IL-8 (CXCL8) <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>, monocyte chemoattractant protein 1 (MCP-1; CCL2) <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>, epithelial neutrophil activating peptide 78 <abbrgrp><abbr bid="B5">5</abbr></abbrgrp>, macrophage inflammatory protein 1 alpha (MIP-1&#945;; CCL3) <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>, macrophage inflammatory protein 1 beta (MIP-1&#946;; CCL4) <abbrgrp><abbr bid="B7">7</abbr></abbrgrp>, RANTES (CCL5) <abbrgrp><abbr bid="B7">7</abbr></abbrgrp> and growth-related gene product alpha (GRO&#945;; CXCL1) <abbrgrp><abbr bid="B8">8</abbr></abbrgrp> (reviewed in <abbrgrp><abbr bid="B9">9</abbr></abbrgrp>). What regulates chemokine gene expression in the RA synovium, however, remains to be determined.</p>
         <p>T cells were recently shown to be essential for the production of proinflammatory cytokines from macrophages in RA synovial tissue <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>. Although synovial CD4<sup>+ </sup>T cells proliferate poorly and produce low levels of IL-2 and interferon gamma <abbrgrp><abbr bid="B10">10</abbr><abbr bid="B11">11</abbr><abbr bid="B12">12</abbr></abbrgrp>, they express cytokines and activation markers <abbrgrp><abbr bid="B13">13</abbr></abbrgrp> &#8211; and when put in contact with synovial fibroblasts or monocytes/macrophages, synovial CD4<sup>+ </sup>T cells induce high levels of inflammatory cytokines <abbrgrp><abbr bid="B14">14</abbr><abbr bid="B15">15</abbr><abbr bid="B16">16</abbr></abbrgrp>.</p>
         <p><it>In vitro</it>, we have shown that T cells activated by an anti-CD3 cross-linking antibody (that mimics TCR engagement (Ttcr)) or stimulated with a 'cocktail' of cytokines (designated cytokine-activated T cells (Tck)) also stimulate monocytes in a contact-dependent manner to produce cytokines that include IL-1&#946;, TNF&#945;, IL-12, IL-6 and IL-10 <abbrgrp><abbr bid="B15">15</abbr><abbr bid="B17">17</abbr><abbr bid="B18">18</abbr><abbr bid="B19">19</abbr><abbr bid="B20">20</abbr><abbr bid="B21">21</abbr></abbrgrp>. While the molecules involved in this process have not been fully defined, a number of T-cell-associated cell surface receptors/ligands, including CD69 <abbrgrp><abbr bid="B17">17</abbr></abbrgrp>, CD40L <abbrgrp><abbr bid="B18">18</abbr></abbrgrp>, CD11b and CD2, have been suggested of importance.</p>
         <p>Histologically, T cells are often found in close contact with macrophages in the interstitium of RA synovial tissue <abbrgrp><abbr bid="B22">22</abbr></abbrgrp> and T-cell depletion rapidly diminishes macrophage TNF&#945; synthesis in RA synovial cultures <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>.</p>
         <p>We previously reported that the contact-dependent effector function of RA T cells in the joint is identical to that displayed by bystander-activated T cells (Tck), which can be expanded from normal blood with a cytokine cocktail containing TNF&#945;, IL-6 and IL-2 over an 8-day period <abbrgrp><abbr bid="B21">21</abbr><abbr bid="B23">23</abbr></abbrgrp>. RA synovial T cells and Tck cells both induce TNF&#945; production in resting monocytes in a cell-contact dependent manner, which is abrogated by blockade of the transcription factor NF&#954;B but is augmented if phosphatidyl-inositol-3-kinase (PI3K) is inhibited. Normal blood T cells activated 'conventionally' via the TCR with cross-linked anti-CD3 antibody result in TNF&#945; production from monocytes that is unaffected by NF&#954;B blockade, but is inhibited in the presence of PI3K blocking drugs <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>.</p>
         <p>In the present report we investigated whether chemokine production from macrophages can also be induced in a contact-dependent manner by activated blood T cells, or indeed by T cells freshly isolated from rheumatoid tissue. We also examined which signalling pathways in macrophages are rate-limiting for the expression of chemokines after T-cell contact, with particular reference to the transcription factor NF&#954;B, in order to gain insight into the regulation of chemokines at sites of inflammation.</p>
      </sec>
      <sec>
         <st>
            <p>Materials and methods</p>
         </st>
         <sec>
            <st>
               <p>Isolation of peripheral blood monocytes and lymphocytes</p>
            </st>
            <p>Human monocytes were isolated from single-donor platelet pheresis residues purchased from the North London Blood Transfusion Service (Colindale, UK). Mononuclear cells were isolated by Ficoll/Hypaque centrifugation (specific density 1.077 g/ml; Nycomed Pharma A.S., Oslo, Norway), prior to cell separation in a Beckman JE6 elutriator (Torrence, CA, USA). Elutriation was performed in culture medium containing 1% heat-inactivated FCS. The monocyte purity and lymphocyte purity were assessed by flow cytometry, and fractions were typically >80% and 90% pure, respectively.</p>
         </sec>
         <sec>
            <st>
               <p>T-cell stimulation and fixation</p>
            </st>
            <p>Elutriation-enriched lymphocytes were resuspended in RPMI 1640 (containing 10% heat-inactivated AB<sup>+ </sup>human serum; (Biowittaker, Wokingham, UK) at 1 &#215; 10<sup>6 </sup>cells/ml. The resuspended lymphocytes were then cultured in six-well cluster culture plates (Falcon, Bedford, MA, USA) at 37&#176;C in a 5% CO<sub>2</sub>/95% air-humidified incubator for 24 hours following stimulation with immobilized anti-CD3 mAb (OKT3; ATCC, Rockville, MD, USA), which had previously been coated onto the six-well culture plates at 10 &#956;g/ml overnight at 4&#176;C.</p>
            <p>Alternatively, T cells were presented with different saturating concentrations of the following: 25 ng/ml TNF&#945; (gift from Dr W. Stec, Centre of Macromolecular Studies, Lodz, Poland), 100 ng/ml IL-6 (gift from Dr P. Ramage, Sandoz, Pharma Ltd., Basel, Switzerland) and 25 ng/ml IL-2 (gift from Dr U Gubler, Hoffmann-LaRoche, Nutley, NJ) for 8 days in culture, prior to fixation.</p>
            <p>In all instances, control T cells were cultured in the absence of any stimulus. Following stimulation, T cells were harvested and washed three times in RPMI 1640 prior to fixation for 1 minute in PBS containing 0.05% glutaraldehyde, and were than neutralized with an equivalent volume of T-cell neutralizing buffer containing 0.2 M glycine. Following a further three washes the fixed T cells were resuspended in complete medium (RPMI 1640 containing 5% heat-inactivated FCS) at 2 &#215; 10<sup>6 </sup>cell/ml and stored for up to 7 days at 4&#176;C until use. The T cells were washed twice in complete medium prior to use.</p>
         </sec>
         <sec>
            <st>
               <p>Isolation of CD3<sup>+ </sup>cells from synovial membrane tissue</p>
            </st>
            <p>Mononuclear cells were obtained from synovial tissue specimens taken during joint replacement surgery, provided by the Orthopedic/Plastic Surgery Department of Charing Cross Hospital, London, UK. Tissue was teased into small pieces and digested in medium containing 0.15 mg/ml DNAase type I (Sigma, Gillingham, Dorset, UK) and 5 mg/ml collagenase (Roche, Welwyn Garden City, Hertfordshire, UK) for 1&#8211;2 hours at 37&#176;C. Cells are passed through a nylon mesh to exclude cell debris, washed and resuspended in RPMI (supplemented with 10% heat-inactivated FCS) at a density of 1 &#215; 10<sup>6 </sup>cells/ml. Mononuclear cells were incubated with anti-CD3 monoclonal antibody-coated Dynabeads for 20 minutes at 4&#176;C under constant rotation. Cells attached to beads were isolated using a magnetic particle concentrator (Dynal, Merseyside, UK) and cultured for 6 hours at 37&#176;C. Detached cells were then removed from the magnetic beads and washed using the magnetic particle concentrator, which allows for isolation of CD3<sup>+ </sup>cells yielding high purity (>99%) and high viability (>95%). Cells were then fixed using the same protocol described above.</p>
         </sec>
         <sec>
            <st>
               <p>Adenoviral vectors and their propagation</p>
            </st>
            <p>Adenoviral gene transfer is a technique used for efficient gene transfer into dividing and nondividing cells, such as fibroblasts and monocytes <abbrgrp><abbr bid="B24">24</abbr><abbr bid="B25">25</abbr></abbrgrp>. Recombinant replication-deficient adenoviral vector containing no insert (Adv0) was provided by M. Wood (University of Oxford, UK), and the adenovirus encoding porcine I&#954;B&#945; with a cytomegalovirus promoter and nuclear localization sequence (AdvI&#954;B&#945;) <abbrgrp><abbr bid="B26">26</abbr></abbrgrp> was provided by Dr R. deMartin (Vienna, Austria). Briefly, viruses were propagated in the 293 human embryonic kidney cell line and purified by ultracentrifugation through two caesium chloride gradients. Titres of viral stocks were determined by plaque assay in 293 cells after exposure to virus for 2 hours in serum-free RPMI 1640, followed by washing and re-culturing the cells in complete medium for 48&#8211;72 hours <abbrgrp><abbr bid="B27">27</abbr></abbrgrp>.</p>
         </sec>
         <sec>
            <st>
               <p>Gene transfer into macrophage-colony stimulating factor-treated monocytes with adenovirus</p>
            </st>
            <p>Prior to adenoviral infection, freshly elutriated monocytes were cultured in a 175 cm<sup>3 </sup>culture flask (Falcon) for 2 days in RPMI 1640 supplemented with 5% heat-inactivated FCS (complete medium) with 50 ng/ml macrophage-colony stimulating factor (M-CSF). This process upregulates the &#945;<sub>v</sub>&#946;<sub>5 </sub>integrin, which acts as a cofactor for adenovirus infection <abbrgrp><abbr bid="B28">28</abbr><abbr bid="B29">29</abbr></abbrgrp>. Following culture, M-CSF-differentiated monocytes were washed once with PBS to remove nonadherent cells and the remaining adherent monocytes were incubated with 10 ml cell dissociation solution (Sigma) for 30&#8211;45 minutes until removed from the plastic. The cell suspension was washed three times in complete medium and the cell viability was assessed by trypan blue exclusion (>90%). Cells were plated at 2 &#215; 10<sup>5</sup>/ml in 96-well flat-bottomed culture plates (Falcon) and were allowed to adhere for 1 hour prior to infection with adenovirus. The media and nonadherent cells were removed from each well and replaced with serum-free RPMI 1640 and adenovirus at the required multiplicity of infection (MOI) for 2 hours. Following incubation, the medium was removed and replaced with complete medium. Monocytes were cultured for a further 2 days before stimulation to enable adenoviral production of I&#954;B&#945; to reach optimal levels.</p>
         </sec>
         <sec>
            <st>
               <p>Coculture of M-CSF-differentiated macrophages and lymphocytes</p>
            </st>
            <p>In the assays for contact-dependent chemokine production, M-CSF-differentiated monocytes (with or without I&#954;B&#945; transduction) were replated at 1 &#215; 10<sup>5 </sup>cells per well on a flat-bottom 96-well plate. Fixed lymphocytes were then added to the wells to give a final T cell:monocyte ratio of 7:1 and a final assay volume of 200 &#956;l. Cultures containing monocytes alone and cultures containing lymphocytes alone were also included as experimental controls. Further controls included cocultures containing a porous membrane insert to physically separate the two populations, while allowing the transition of soluble mediators (0.2 &#956;m Anopore<sup>&#174; </sup>Membrane Nunc Tissue Culture Inserts; Nunc, Roskilde, Denmark). After 18 hours of culture at 37&#176;C (5% CO2, humidified atmosphere), the supernatants were harvested and stored at -70&#176;C for subsequent chemokine assay.</p>
         </sec>
         <sec>
            <st>
               <p>Measurement of chemokines by sandwich ELISA</p>
            </st>
            <p>Concentrations of IL-8 (CXCL8) (PharMingen, San Diego, CA, USA), GRO&#945; (CXCL1), interferon-gamma-inducible protein 10 (IP-10) (CXCL10), MCP-1 (CCL2), MIP-1&#945; (CCL3), MIP-1&#946; (CCL4) and RANTES (CCL5) were determined by ELISA (R&amp;D Systems, <b>Oxford</b>, UK), following the manufacturer's instructions. The absorbance was read and analysed at 450 nm on a spectrophotometric ELISA plate reader (Labsystems Multiskan Biochromic, Labsystems, Uxbridge, UK) using the Delta soft II.4 software programme (DeltaSoft Inc, Hillsborough, NJ, USA). Results are expressed as the mean concentration of triplicate cultures &#177; standard deviation.</p>
         </sec>
         <sec>
            <st>
               <p>Statistical analysis</p>
            </st>
            <p>Results were examined for statistical differences using Student's <it>t </it>test (two-tailed). <it>P </it>&lt; 0.05 was considered significant, and such values are illustrated on the figures as appropriate.</p>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <sec>
            <st>
               <p>Both Tck cells and Ttcr cells induce contact-dependent chemokine production by M-CSF-differentiated human monocytes</p>
            </st>
            <p>We have previously reported that the production of proinflammatory cytokines by macrophages can be induced by cognate interaction with Ttcr cells or Tck cells <abbrgrp><abbr bid="B19">19</abbr><abbr bid="B21">21</abbr></abbrgrp>. In the present paper we investigated whether activated T cells can also induce macrophage CC or CXC chemokine secretion in a contact-dependent manner. We found that, upon coculture, T cells activated with anti-CD3 antibody are able to induce production of high levels of chemokines in M-CSF-differentiated human monocytes (macrophages). Levels of both CC chemokines (MCP-1, MIP-1&#945;, MIP-1&#946; and RANTES) and CXC chemokines (IL-8, GRO&#945; and IP-10) are all elevated in comparison with those found in cultures of M-CSF-differentiated monocytes alone (Figure <figr fid="F1">1a</figr>). This induction of chemokine production in monocytes can be significantly reduced if the monocytes and T cells are physically separated using a porous membrane insert, demonstrating the importance of cell-cell contact in the induction process. In contrast, chemokine production by M-CSF-differentiated monocytes alone remains unchanged following coculture with unstimulated T cells (cultured for 24 hours prior to fixation).</p>
            <fig id="F1">
               <title>
                  <p>Figure 1</p>
               </title>
               <caption>
                  <p>Activated T cells induce contact-dependent chemokine production by human macrophages</p>
               </caption>
               <text>
                  <p>Activated T cells induce contact-dependent chemokine production by human macrophages. Lymphocytes were left unstimulated or were stimulated with either anti-CD3 for 48 hours (Ttcr cells) or a 'cocktail' of inflammatory cytokines (tumour necrosis factor alpha (TNF&#945;), IL-2, IL-6) (Tck cells) for 8 days, before fixation. The unstimulated, Ttcr and Tck populations were then cultured with macrophage-colony stimulating factor-differentiated monocytes (ratio 7:1) for 18 hours. Culture supernatants were then isolated and levels of CC chemokines (monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1&#945;), macrophage inflammatory protein 1 beta (MIP-1&#946;), RANTES) and CXC chemokines (IL-8, growth-related gene product alpha (GRO&#945;) and interferon-gamma-inducible protein (IP-10)) measured by ELISA. In some cases, a porous membrane insert was used to physically separate the two populations, while allowing the transition of soluble mediators. Results are shown from <b>(a) </b>Ttcr-cell lymphocyte cultures and <b>(b) </b>Tck-cell lymphocyte cultures. Data represent a mean of triplicate cultures &#177; standard deviation and are representative of at least three experiments. Statistically significant differences in chemokine detection are indicated.</p>
               </text>
               <graphic file="ar2077-1"/>
            </fig>
            <p>Tck cells were also cultured with M-CSF-differentiated monocytes (Figure <figr fid="F1">1b</figr>). Tck cells, as seen with Ttcr cells, were able to induce significant production of all CC chemokines (MCP-1, MIP-1&#945;, MIP 1&#946; and RANTES) and CXC chemokines (IL-8, GRO&#945; and IP-10) assayed to similar levels, again in a contact-dependent manner. As expected, fixed Ttcr and Tck cells cultured alone did not secrete any detectable levels of chemokines (data not shown). Moreover, macrophages cultured in the presence of the insert and stimulated with lipopolysaccharide (LPS) secreted high levels of chemokines (data not shown) as previously described <abbrgrp><abbr bid="B30">30</abbr></abbrgrp>, indicating that the presence of the membrane insert does not influence macrophage function.</p>
         </sec>
         <sec>
            <st>
               <p>Differential utilization of NF&#954;B in the Ttcr-cell and Tck-cell contact-dependent induction of CC and CXC chemokines in M-CSF-differentiated monocytes</p>
            </st>
            <p>We have previously shown that the contact-dependent induction of TNF&#945; production in resting monocytes by Tck cells or RA synovial T cells is abrogated by blockade of the transcription factor NF&#954;B <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>. As NF&#954;B is a major transcription factor regulating the expression of numerous genes involved in immune and inflammatory responses <abbrgrp><abbr bid="B28">28</abbr><abbr bid="B31">31</abbr></abbrgrp>, we determined whether T-cell contact-dependent production of chemokines is also regulated by NF&#954;B.</p>
            <p>To inhibit NF&#954;B with specificity we employed an efficient adenoviral gene transfer method to overexpress I&#954;B&#945; in human macrophages. We have previously shown that high levels of I&#954;B&#945; are achieved by AdvI&#954;B&#945; transduction that remain elevated even after LPS stimulation <abbrgrp><abbr bid="B30">30</abbr></abbrgrp>. As I&#954;B&#945; is a major inhibitory component of the NF&#954;B pathway, increased expression of I&#954;B&#945; blocks NF&#954;B nuclear translocation and DNA binding induced by LPS.</p>
            <p>We then examined whether I&#954;B&#945; overexpression inhibits monocyte chemokine production induced by Ttcr cells. We found that AdI&#954;B&#945; inhibits the production of CC chemokines induced by contact with Ttcr cells but has no effect on CXC chemokine induction. MIP-1&#945; production induced by Ttcr cells was therefore profoundly reduced, in a dose-dependent manner, in M-CSF-differentiated monocytes infected with AdI&#954;B&#945; but not with Ad0, a control virus without insert. At MOI of 40:1 and 80:1, the inhibition of MIP-1&#945; expression was 54% (<it>P </it>&#8804; 0.005) and 78% (<it>P </it>&#8804; 0.005), respectively &#8211; which was not further increased at higher MOI (Figure <figr fid="F2">2a</figr>).</p>
            <fig id="F2">
               <title>
                  <p>Figure 2</p>
               </title>
               <caption>
                  <p>Differential utilization of NF&#954;B in activated-T-cell contact-dependent chemokine production by human macrophages</p>
               </caption>
               <text>
                  <p>Differential utilization of NF&#954;B in activated-T-cell contact-dependent chemokine production by human macrophages. Macrophage-colony stimulating factor-differentiated monocytes were infected with AdI&#954;B&#945; or Ad0, an empty control virus. After a further 2 days of culture and replating, anti-CD3-activated T cells (Ttcr cells) and cytokine-activated T cells (Tck cells) were added at a lymphocyte:monocyte ratio of 7:1. After 18 hours, culture supernatants were isolated and levels of CC chemokines (monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1&#945;), macrophage inflammatory protein 1 beta (MIP-1&#946;), RANTES) and CXC chemokines (IL-8, growth-related gene product alpha (GRO&#945;) and interferon-gamma-inducible protein (IP-10)) were measured simultaneously by ELISA. <b>(a) </b>MIP-1&#945; levels in uninfected, Ad0-infected (multiplicity of infection (MOI) 200:1) and AdI&#954;B&#945;-infected (MOI 40:1, 80:1 and 200:1) monocyte cultures when stimulated with Ttcr-cells or Tck-cells. <b>(b) </b>and <b>(c) </b>Levels of CC and CXC chemokines in Ad0-infected and AdI&#954;B&#945;-infected monocytes (MOI 80:1) following stimulation with (b) Ttcr cells and (c) Tck cells. Data represent the mean of triplicate cultures &#177; standard deviation and are representative of at least three experiments. Statistically significant reduction in chemokine levels in AdvI&#954;B&#945;-infected (as compared with Ad0-infected) cultures is indicated.</p>
               </text>
               <graphic file="ar2077-2"/>
            </fig>
            <p>Similar significant inhibition of the production of the other CC chemokines MIP1-&#946; (73.9%, <it>P </it>&#8804; 0.005), RANTES (70.2%, <it>P </it>&#8804; 0.005) and MCP-1 (67%, <it>P </it>&#8804; 0.005) was also observed in AdI&#954;B&#945;-infected monocytes (Figure <figr fid="F2">2b</figr>). In contrast, there was no effect of I&#954;B&#945; overexpression on CXC chemokine production. We found that there was no significant inhibition of the chemokines GRO&#945;, I,L-8 or IP-10 in AdI&#954;B&#945;-infected monocytes activated by Ttcr cells, suggesting that there is differential utilization of NF&#954;B for the expression of CC and CXC chemokines in this system.</p>
            <p>We also examined the role of NF&#954;B in the Tck-cell contact-dependent production of chemokines in monocytes. Unexpectedly, we found that I&#954;B&#945; overexpression inhibited Tck-cell-dependent CXC chemokine production in M-CSF-differentiated monocytes, but had no effect in CC chemokine production. Thus, although contact-dependent induction of GRO&#945;, IL-8 and IP-10 was significantly inhibited in AdI&#954;B&#945;-infected macrophages by 78.7% (<it>P </it>&#8804; 0.01), 63.2% (<it>P </it>&#8804; 0.01) and 52.1% (<it>P </it>&#8804; 0.05), respectively, the induction of MIP-1&#945;, MIP-1&#946;, RANTES and MCP-1 was unaffected (Figure <figr fid="F2">2c</figr>). This inverted pattern of utilization of NF&#954;B for the T-cell contact-dependent induction of CC and CXC chemokines in monocytes is surprising and indicates that chemokine gene expression may be more complex than previously thought.</p>
         </sec>
         <sec>
            <st>
               <p>I&#954;B&#945; overexpression significantly inhibits rheumatoid T-cell-induced macrophage secretion of CXC, but not CC, chemokines</p>
            </st>
            <p>We next investigated whether RA synovial T cells enriched from dissociated RA synovial tissue could also induce monocyte chemokine secretion in a contact-dependent manner and whether this requires NF&#954;B. RA synovial T cells were isolated from dissociated synovial membranes using anti-CD3 DynaBeads, as described in Materials and methods. We found that, like Ttcr and Tck cells, fixed RA synovial T cells were able to induce both CC and CXC chemokine production from M-CSF-differentiated human monocytes (Figure <figr fid="F3">3</figr>). Furthermore, overexpression of I&#954;B&#945; in these monocytes resulted in impaired RA synovial T cell-dependent CXC chemokine release, when compared with Ad0-infected monocytes. A significant reduction in IL-8 (54.1%, <it>P </it>&#8804; 0.01), IP-10 (39.6%, <it>P </it>&#8804; 0.05) and GRO&#945; (74.2%, <it>P </it>&#8804; 0.01) production was therefore observed (Figure <figr fid="F3">3a</figr>). This effect was dose dependent, with increasing MOI of 40:1 and 80:1 inducing a reduction in GRO&#945; levels of 55.1% (<it>P </it>&#8804; 0.01) and an optimal 74.2% (<it>P </it>&#8804; 0.001), respectively (Figure <figr fid="F3">3b</figr>).</p>
            <fig id="F3">
               <title>
                  <p>Figure 3</p>
               </title>
               <caption>
                  <p>I&#954;B&#945; overexpression significantly inhibits rheumatoid T-cell-induced macrophage chemokine secretion of CXC, but not CC, chemokines</p>
               </caption>
               <text>
                  <p>I&#954;B&#945; overexpression significantly inhibits rheumatoid T-cell-induced macrophage chemokine secretion of CXC, but not CC, chemokines. Using anti-CD3 labelled Dynabeads, synovial T cells were enriched from the mixed cell population obtained following enzymatic dissociation of synovial tissue samples from rheumatoid arthritis (RA) patients. Fixed RA T cells were cultured with macrophage-colony stimulating factor-differentiated monocytes infected with Ad0 and AdvI&#954;B&#945; at a T cell:monocyte ratio of 7:1 as described in Figure 2. After 18 hours, culture supernatants were isolated and levels of CC chemokines (monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1&#945;), macrophage inflammatory protein 1 beta (MIP-1&#946;), RANTES) and CXC chemokines (IL-8, growth-related gene product alpha (GRO&#945;) and interferon-gamma-inducible protein (IP-10)) were measured by ELISA. <b>(a) </b>Levels of chemokines for monocytes infected with Ad0 and AdI&#954;B&#945; (multiplicity of infection (MOI) 80:1) following stimulation with RA T cells. <b>(b) </b>GRO&#945; levels in uninfected, Ad0-infected (MOI 200:1) and AdvI&#954;B&#945;-infected (MOI 20:1, 40, 80:1 and 200:1) monocyte cultures when stimulated with RA T cells. Data represent the mean of triplicate cultures &#177; standard deviation and are representative of at least three experiments. Statistically significant reduction in chemokine levels in AdI&#954;B&#945;-infected (as compared with Ad0-infected) cultures is indicated.</p>
               </text>
               <graphic file="ar2077-3"/>
            </fig>
            <p>Similar dose-dependent profiles were observed for the other chemokines tested (data not shown). Interestingly, however, overexpression of I&#954;B&#945; had no significant effect on the expression of CC chemokines by M-CSF-differentiated monocytes, suggesting that RA synovial T cells possess similarities in their effector function to Tck cells, rather than Ttcr cells. It is noteworthy that RA T cells isolated based on CD2 expression have previously demonstrated an identical effector function to those isolated using anti-CD3 (data not shown), thus discounting the idea that CD3-based methods may influence the behaviour of RA T cells (through the potential for crosslinking) in this system.</p>
         </sec>
         <sec>
            <st>
               <p>The phosphatidyl-inositol-3-kinase pathway regulates both NF&#954;B-dependent and NF&#954;B-independent contact-mediated chemokine production</p>
            </st>
            <p>Finally, we investigated what further cell signalling pathways (in addition to NF&#954;B) could play a potential role in contact-dependent chemokine production. Ttcr cells and Tck cells were used to stimulate monocytes that had been pretreated with a chemical inhibitor of the PI3K pathway (LY294002), and the resulting effects on chemokine production were determined. We found that Ttcr-induced IP-10 (CXC chemokine) production (NF&#954;B independent) was dose-dependently reduced in the presence of the inhibitor (Figure <figr fid="F4">4b</figr>). In contrast, Tck-induced MIP-1&#945; (CC chemokine) production (also NF&#954;B independent) could be dose-dependently enhanced in the presence of the PI3K inhibitor (Figure <figr fid="F4">4a</figr>), indicating the pathway plays a positive and negative regulatory role in each respective case. With NF&#954;B-dependent Ttcr-induced MIP-1&#945; production also displaying PI3K dependence, however, a role for this pathway in NF&#954;B-dependent as well as NF&#954;B-independent chemokine production cannot be ruled out.</p>
            <fig id="F4">
               <title>
                  <p>Figure 4</p>
               </title>
               <caption>
                  <p>The phosphatidyl-inositol-3-kinase pathway regulates both NF&#954;B-dependent and NF&#954;B-independent contact-dependent chemokine production</p>
               </caption>
               <text>
                  <p>The phosphatidyl-inositol-3-kinase pathway regulates both NF&#954;B-dependent and NF&#954;B-independent contact-dependent chemokine production. Macrophage-colony stimulating factor-differentiated monocytes were preincubated for 30 minutes in the presence or absence of variable amounts of LY294002 (as shown) before being stimulated with anti-CD3-activated T cells (Ttcr) or cytokine-activated T cells (Tck) at a T cell:monocyte ratio of 7:1. After 18 hours, culture supernatants were isolated and levels of <b>(a) </b>macrophage inflammatory protein 1 alpha (MIP-1&#945;) (CC chemokine) and <b>(b) </b>interferon-gamma-inducible protein (IP-10) (CXC chemokine) were measured by ELISA. Data represent the mean of triplicate cultures &#177; standard deviation and are representative of at least three experiments.</p>
               </text>
               <graphic file="ar2077-4"/>
            </fig>
         </sec>
      </sec>
      <sec>
         <st>
            <p>Discussion</p>
         </st>
         <p>We have previously shown that TNF&#945; synthesis in RA synovial cultures is T-cell contact-dependent; T-cell depletion or physical separation from the rest of the cells rapidly diminished macrophage TNF&#945; production in these cultures <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>. We have also shown that the contact-dependent effector function of RA T cells in the joint resembles that displayed by Tck cells, which can be expanded from normal blood with cytokines found in the RA joint and in the absence of TCR engagement <abbrgrp><abbr bid="B21">21</abbr><abbr bid="B23">23</abbr></abbrgrp>. Both RA synovial T cells without further activation and Tck cells induced TNF&#945; production in resting monocytes in a cell-contact dependent manner, which was abrogated by blockade of the transcription factor NF&#954;B but was augmented if PI3K was inhibited. Normal blood T cells activated 'conventionally' via the TCR with cross-linked anti-CD3 antibody (Ttcr cells) do not reproduce this effector function of RA T cells <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>. In this study, we investigated whether Tck cells or RA synovial T cells also regulate chemokine production from macrophages and whether this was mediated in a contact-dependent manner.</p>
         <p>Using a coculture system consisting of fixed lymphocytes and M-CSF-differentiated human monocytes <abbrgrp><abbr bid="B21">21</abbr><abbr bid="B23">23</abbr></abbrgrp>, we demonstrate in this manuscript that Tck cells stimulate monocytes to secrete high levels of several CC and CXC chemokines that include MIP-1&#945;, MIP-1&#946;, RANTES, MCP-1, GRO&#945;, IL-8 and IP-10. This was a T-cell contact-dependent process as the physical separation of T cells from monocytes through the use of a transwell insert abrogated this effect. This observation was also true for Ttcr cells and RA synovial T cells but not for control nonactivated T cells, suggesting that contact-dependent regulation of macrophage chemokine production is a general property of activated T cells. Several other groups have also shown the importance of T-cell contact in regulating the production of cytokines and tissue destructive enzymes (such as matrix metalloproteinases) by monocyte/macrophages <abbrgrp><abbr bid="B15">15</abbr><abbr bid="B17">17</abbr><abbr bid="B18">18</abbr><abbr bid="B19">19</abbr><abbr bid="B20">20</abbr><abbr bid="B21">21</abbr><abbr bid="B32">32</abbr></abbrgrp> and fibroblasts, suggesting that this may be a major mechanism of promoting inflammation in chronic inflammatory diseases where there is an absence of infection or infectious agents <abbrgrp><abbr bid="B33">33</abbr></abbrgrp>.</p>
         <p>Various stimuli induce T cells to activate monocytes/macrophages by cellular contact, including anti-CD3 cross-linking with or without anti-CD28 stimulation (as used in this study) <abbrgrp><abbr bid="B34">34</abbr></abbrgrp>, cytokines such as IL-2, IL-6 and TNF&#945; (as used in this study) <abbrgrp><abbr bid="B19">19</abbr></abbrgrp> or IL-15 <abbrgrp><abbr bid="B15">15</abbr></abbrgrp>, phytohaemagluttinin/phorbol myristate acetate <abbrgrp><abbr bid="B17">17</abbr><abbr bid="B35">35</abbr><abbr bid="B36">36</abbr></abbrgrp> and antigen recognition on antigen-specific T-cell clones of the Th1 or Th2 phenotype <abbrgrp><abbr bid="B37">37</abbr><abbr bid="B38">38</abbr></abbrgrp>. Depending on the T-cell type and the stimulus used, the pattern of gene expression triggered in monocytes/macrophages by T-cell contact differs. We have previously shown that although Ttcr cells activate monocytes to produce both TNF&#945; and IL-10, Tck cells only trigger the production of TNF&#945; in monocytes, suggesting that this is a mechanism by which the cytokine balance is skewed towards the proinflammatory side in RA <abbrgrp><abbr bid="B19">19</abbr></abbrgrp>. Other studies have shown that Th1 clones preferentially induce IL-1&#946; rather than IL-1 receptor antagonist over other T-cell clones <abbrgrp><abbr bid="B38">38</abbr><abbr bid="B39">39</abbr></abbrgrp>. This suggests that multiple ligands and counter-ligands are involved in the contact-mediated activation of monocytes/macrophages that are differentially induced on T cells (depending on the stimulus) and differentially induce monocyte/macrophage signal transduction.</p>
         <p>The transcription factor NF&#954;B has been shown to regulate both inflammatory and tissue destructive processes in RA <abbrgrp><abbr bid="B25">25</abbr><abbr bid="B40">40</abbr></abbrgrp>. Many of the promoter regions of chemokines are known to have &#954;B sites in their promoters and include IL-8 <abbrgrp><abbr bid="B41">41</abbr></abbrgrp>, GRO&#945; <abbrgrp><abbr bid="B42">42</abbr></abbrgrp>, IP-10 <abbrgrp><abbr bid="B43">43</abbr></abbrgrp>, MCP-1 <abbrgrp><abbr bid="B44">44</abbr></abbrgrp>, and RANTES <abbrgrp><abbr bid="B45">45</abbr></abbrgrp>. We recently used adenoviral gene transfer of I&#954;B&#945; to block NF&#954;B in human M-CSF-differentiated monocytes, and showed that the expression of CC chemokines MIP-1&#945;, MCP-1 and RANTES induced by TNF&#945; or LPS was NF&#954;B dependent, as was the expression of CXC chemokines IL-8, GRO&#945; and epithelial neutrophil activating peptide 78 induced by TNF&#945; <abbrgrp><abbr bid="B30">30</abbr></abbrgrp>. The expression of these CXC chemokines induced by LPS, however, was found to be NF&#954;B independent &#8211; indicating that the requirement for this transcription factor in the regulation of chemokine gene expression is complex and dependent on the stimuli used.</p>
         <p>In this study, we used the same system of adenovirally mediated I&#954;B&#945; overexpression in M-CSF-differentiated monocytes to investigate the potential involvement of NF&#954;B in the expression of CC and CXC chemokines induced by contact with activated T cells or RA synovial T cells. Surprisingly, we found that blocking NF&#954;B resulted in differential inhibition of CC and CXC chemokines depending on whether Ttcr cells, Tck cells or rheumatoid T cells were used to stimulate M-CSF-differentiated monocytes. CC chemokine production was thus found to be NF&#954;B dependent when mediated by Ttcr cells, but NF&#954;B independent when mediated by Tck or RA synovial T cells. In addition, CXC chemokine production was found to be NF&#954;B independent when mediated by Ttcr cells, but largely NF&#954;B dependent when mediated by Tck or RA synovial T cells. These data suggest that, through different molecular interactions, at least two differential pathways of monocyte chemokine production are induced by Ttcr cells and Tck cells that differ in the rate-limiting involvement of NF&#954;B. Evidence from our inhibitor studies suggest involvement of the PI3K pathway in regulating both NF&#954;B-independent and NF&#954;B-dependent chemokine production, in either a positive or negative manner, depending on chemokine and lymphocyte stimulus. We have previously published work showing a similar augmentation of Tck/RA T-cell-induced TNF&#945; production in the presence of these inhibitors <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>.</p>
         <p>As the promoters of all the chemokines studied here contain NF&#954;B binding sites, this raises the obvious question of how this effect is regulated. Currently unclear is whether these specific sites are functioning as positive or negative regulators of transcription; a process that could itself be influenced by which other pathways are also activated. For example, TNF&#945; production in T cells is known to be regulated by nuclear factor of activated T cells although the TNF gene contains at least five NF&#954;B sites <abbrgrp><abbr bid="B46">46</abbr></abbrgrp>. Furthermore, variable factors such as the site sequence and its distance from the transcription start site, as well as the nature of the different NF&#954;B dimers recruited to the site, will all interact to influence gene expression <abbrgrp><abbr bid="B47">47</abbr></abbrgrp>.</p>
         <p>A further layer of complexity operating in this system is the role of contact-induced TNF&#945; in secondary chemokine production. We have previously shown TNF&#945; production itself is differently dependent on NF&#954;B and the PI3K pathway (similarly regulating either positively or negatively) according to Ttcr-cell or Tck-cell induction processes. As such, effects on both pathways could be acting on chemokine induction in direct and indirect ways. Furthermore, our previous studies have shown both Ttcr-cell-induced and Tck-cell-induced TNF&#945; production to be p38MAPK dependent, but p42/p44 MAPK independent (data not shown), indicating that mitogen-activated protein kinases may also be involved in contact-dependent chemokine induction.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>This study demonstrates for the first time that RA synovial T cells as well as Tck cells are able to induce monocyte chemokine production in a contact-dependent manner and through NF&#954;B-dependent and NF&#954;B-independent mechanisms, in a process influenced by the PI3K pathway. In addition, these data provide further evidence that Tck cells share aspects of their effector function (such as contact-mediated monocyte chemokine production) with RA synovial T cells. Furthermore, these data demonstrate one more function of RA T cells; namely, their ability to induce monocyte/macrophage chemokine secretion by cellular contact. The observation that RA synovial T cells mirror the behaviour of cytokine-driven, rather than CD3-activated, cells is consistent with the notion that antigen-independent responses play a key role in RA. As such, this study further emphasizes that T cells are not simply 'innocent bystanders' in RA, but can be important drivers of chronic inflammation through antigen-independent mechanisms <abbrgrp><abbr bid="B48">48</abbr><abbr bid="B49">49</abbr></abbrgrp>.</p>
      </sec>
      <sec>
         <st>
            <p>Abbreviations</p>
         </st>
         <p>ELISA = enzyme-linked immunosorbent assay; FCS = foetal calf serum; GRO&#945; = growth-related gene product alpha; IL = interleukin; IP-10 = interferon-gamma-inducible protein 10; LPS = lipopolysaccharide; mAb = monoclonal antibody; MCP-1 = monocyte chemoattractant protein 1; M-CSF = macrophage-colony stimulating factor; MIP-1&#945; = macrophage inflammatory protein 1 alpha; MIP-1&#946; = macrophage inflammatory protein 1 beta; MOI = multiplicity of infection; NF&#954;B = nuclear factor kappa B; PBS = phosphate-buffered saline; PI3K = phosphatidyl-inositol-3-kinase; RA = rheumatoid arthritis; Tck cells = cytokine-activated T cells; TCR = T-cell receptor; Ttcr cells = anti-CD3-activated T cells; TNF&#945; = tumour necrosis factor alpha.</p>
      </sec>
      <sec>
         <st>
            <p>Competing interests</p>
         </st>
         <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec>
         <st>
            <p>Authors' contributions</p>
         </st>
         <p>JTB participated in data analysis, assembly and creation of the figures, and manuscript writing. EA contributed to the study design, experimentation, data analysis, assembly and creation of the figures, and manuscript writing. CJC was involved in the study design, experimentation and data analysis. PG contributed to the study design, experimentation, data analysis, and assembly and creation of the figures. BMJF and FMB were responsible for the initiation of the study, review of the analysed data and manuscript writing.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Role of cytokines in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Maini</snm>
                  <fnm>RN</fnm>
               </au>
            </aug>
            <source>Annu Rev Immunol</source>
            <pubdate>1996</pubdate>
            <volume>14</volume>
            <fpage>397</fpage>
            <lpage>440</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1146/annurev.immunol.14.1.397</pubid>
                  <pubid idtype="pmpid" link="fulltext">8717520</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>Cytokines and anti-cytokine biologicals in autoimmunity: present and future</p>
            </title>
            <aug>
               <au>
                  <snm>Andreakos</snm>
                  <fnm>ET</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Maini</snm>
                  <fnm>RN</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Cytokine Growth Factor Rev</source>
            <pubdate>2002</pubdate>
            <volume>13</volume>
            <fpage>299</fpage>
            <lpage>313</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S1359-6101(02)00018-7</pubid>
                  <pubid idtype="pmpid" link="fulltext">12220545</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells</p>
            </title>
            <aug>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Zachariae</snm>
                  <fnm>CO</fnm>
               </au>
               <au>
                  <snm>Chantry</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Larsen</snm>
                  <fnm>CG</fnm>
               </au>
               <au>
                  <snm>Turner</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Maini</snm>
                  <fnm>RN</fnm>
               </au>
               <au>
                  <snm>Matsushima</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1990</pubdate>
            <volume>20</volume>
            <fpage>2141</fpage>
            <lpage>2144</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmpid">2209707</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B4">
            <title>
               <p>Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Koch</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Kunkel</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Harlow</snm>
                  <fnm>LA</fnm>
               </au>
               <au>
                  <snm>Johnson</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Evanoff</snm>
                  <fnm>HL</fnm>
               </au>
               <au>
                  <snm>Haines</snm>
                  <fnm>GK</fnm>
               </au>
               <au>
                  <snm>Burdick</snm>
                  <fnm>MD</fnm>
               </au>
               <au>
                  <snm>Pope</snm>
                  <fnm>RM</fnm>
               </au>
               <au>
                  <snm>Strieter</snm>
                  <fnm>RM</fnm>
               </au>
            </aug>
            <source>J Clin Invest</source>
            <pubdate>1992</pubdate>
            <volume>90</volume>
            <fpage>772</fpage>
            <lpage>779</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">329929</pubid>
                  <pubid idtype="pmpid">1522232</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B5">
            <title>
               <p>Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Koch</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Kunkel</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Harlow</snm>
                  <fnm>LA</fnm>
               </au>
               <au>
                  <snm>Mazarakis</snm>
                  <fnm>DD</fnm>
               </au>
               <au>
                  <snm>Haines</snm>
                  <fnm>GK</fnm>
               </au>
               <au>
                  <snm>Burdick</snm>
                  <fnm>MD</fnm>
               </au>
               <au>
                  <snm>Pope</snm>
                  <fnm>RM</fnm>
               </au>
               <au>
                  <snm>Walz</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Strieter</snm>
                  <fnm>RM</fnm>
               </au>
            </aug>
            <source>J Clin Invest</source>
            <pubdate>1994</pubdate>
            <volume>94</volume>
            <fpage>1012</fpage>
            <lpage>1018</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">295150</pubid>
                  <pubid idtype="pmpid">8083342</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B6">
            <title>
               <p>Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Koch</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Kunkel</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Harlow</snm>
                  <fnm>LA</fnm>
               </au>
               <au>
                  <snm>Mazarakis</snm>
                  <fnm>DD</fnm>
               </au>
               <au>
                  <snm>Haines</snm>
                  <fnm>GK</fnm>
               </au>
               <au>
                  <snm>Burdick</snm>
                  <fnm>MD</fnm>
               </au>
               <au>
                  <snm>Pope</snm>
                  <fnm>RM</fnm>
               </au>
               <au>
                  <snm>Strieter</snm>
                  <fnm>RM</fnm>
               </au>
            </aug>
            <source>J Clin Invest</source>
            <pubdate>1994</pubdate>
            <volume>93</volume>
            <fpage>921</fpage>
            <lpage>928</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">293992</pubid>
                  <pubid idtype="pmpid">8132778</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B7">
            <title>
               <p>Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells</p>
            </title>
            <aug>
               <au>
                  <snm>Robinson</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Keystone</snm>
                  <fnm>EC</fnm>
               </au>
               <au>
                  <snm>Schall</snm>
                  <fnm>TJ</fnm>
               </au>
               <au>
                  <snm>Gillett</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Fish</snm>
                  <fnm>EN</fnm>
               </au>
            </aug>
            <source>Clin Exp Immunol</source>
            <pubdate>1995</pubdate>
            <volume>101</volume>
            <fpage>398</fpage>
            <lpage>407</lpage>
            <xrefbib>
               <pubid idtype="pmpid">7545093</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B8">
            <title>
               <p>Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Koch</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Kunkel</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Shah</snm>
                  <fnm>MR</fnm>
               </au>
               <au>
                  <snm>Hosaka</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Halloran</snm>
                  <fnm>MM</fnm>
               </au>
               <au>
                  <snm>Haines</snm>
                  <fnm>GK</fnm>
               </au>
               <au>
                  <snm>Burdick</snm>
                  <fnm>MD</fnm>
               </au>
               <au>
                  <snm>Pope</snm>
                  <fnm>RM</fnm>
               </au>
               <au>
                  <snm>Strieter</snm>
                  <fnm>RM</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1995</pubdate>
            <volume>155</volume>
            <fpage>3660</fpage>
            <lpage>3666</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">7561066</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B9">
            <title>
               <p>Chemokines and chemokine receptors in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Szekanecz</snm>
                  <fnm>Z</fnm>
               </au>
               <au>
                  <snm>Kim</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Koch</snm>
                  <fnm>AE</fnm>
               </au>
            </aug>
            <source>Semin Immunol</source>
            <pubdate>2003</pubdate>
            <volume>15</volume>
            <fpage>15</fpage>
            <lpage>21</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S1044-5323(02)00124-0</pubid>
                  <pubid idtype="pmpid">12495637</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B10">
            <title>
               <p>Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Emery</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Panayi</snm>
                  <fnm>GS</fnm>
               </au>
               <au>
                  <snm>Nouri</snm>
                  <fnm>AM</fnm>
               </au>
            </aug>
            <source>Clin Exp Immunol</source>
            <pubdate>1984</pubdate>
            <volume>57</volume>
            <fpage>123</fpage>
            <lpage>129</lpage>
            <xrefbib>
               <pubid idtype="pmpid">6611230</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B11">
            <title>
               <p>Subpopulations of primed T helper cells in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Matthews</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Emery</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Pilling</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Akbar</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Salmon</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>1993</pubdate>
            <volume>36</volume>
            <fpage>603</fpage>
            <lpage>607</lpage>
            <xrefbib>
               <pubid idtype="pmpid">8098214</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B12">
            <title>
               <p>Quantitative analysis of cytokine gene expression in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Firestein</snm>
                  <fnm>GS</fnm>
               </au>
               <au>
                  <snm>Alvaro-Gracia</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Maki</snm>
                  <fnm>R</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1990</pubdate>
            <volume>144</volume>
            <fpage>3347</fpage>
            <lpage>3353</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">2109776</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B13">
            <title>
               <p>Flow cytometric single-cell analysis of cytokine production by CD4<sup>+</sup>T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Morita</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Yamamura</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Kawashima</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Harada</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Tsuji</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Shibuya</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Maruyama</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Makino</snm>
                  <fnm>H</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>1998</pubdate>
            <volume>41</volume>
            <fpage>1669</fpage>
            <lpage>1676</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/1529-0131(199809)41:9&lt;1669::AID-ART19>3.0.CO;2-G</pubid>
                  <pubid idtype="pmpid">9751101</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B14">
            <title>
               <p>The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis [see comments]</p>
            </title>
            <aug>
               <au>
                  <snm>McInnes</snm>
                  <fnm>IB</fnm>
               </au>
               <au>
                  <snm>al-Mughales</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Field</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Leung</snm>
                  <fnm>BP</fnm>
               </au>
               <au>
                  <snm>Huang</snm>
                  <fnm>FP</fnm>
               </au>
               <au>
                  <snm>Dixon</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Sturrock</snm>
                  <fnm>RD</fnm>
               </au>
               <au>
                  <snm>Wilkinson</snm>
                  <fnm>PC</fnm>
               </au>
               <au>
                  <snm>Liew</snm>
                  <fnm>FY</fnm>
               </au>
            </aug>
            <source>Nat Med</source>
            <pubdate>1996</pubdate>
            <volume>2</volume>
            <fpage>175</fpage>
            <lpage>182</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/nm0296-175</pubid>
                  <pubid idtype="pmpid">8574962</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B15">
            <title>
               <p>Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-&#945; production in rheumatoid arthritis [see comments]</p>
            </title>
            <aug>
               <au>
                  <snm>McInnes</snm>
                  <fnm>IB</fnm>
               </au>
               <au>
                  <snm>Leung</snm>
                  <fnm>BP</fnm>
               </au>
               <au>
                  <snm>Sturrock</snm>
                  <fnm>RD</fnm>
               </au>
               <au>
                  <snm>Field</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Liew</snm>
                  <fnm>FY</fnm>
               </au>
            </aug>
            <source>Nat Med</source>
            <pubdate>1997</pubdate>
            <volume>3</volume>
            <fpage>189</fpage>
            <lpage>195</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/nm0297-189</pubid>
                  <pubid idtype="pmpid">9018238</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B16">
            <title>
               <p>Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis</p>
            </title>
            <aug>
               <au>
                  <snm>McInnes</snm>
                  <fnm>IB</fnm>
               </au>
               <au>
                  <snm>Liew</snm>
                  <fnm>FY</fnm>
               </au>
            </aug>
            <source>Immunol Today</source>
            <pubdate>1998</pubdate>
            <volume>19</volume>
            <fpage>75</fpage>
            <lpage>79</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0167-5699(97)01205-X</pubid>
                  <pubid idtype="pmpid" link="fulltext">9509762</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B17">
            <title>
               <p>Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1&#946; by monocytic cells: a possible role of CD69</p>
            </title>
            <aug>
               <au>
                  <snm>Isler</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Vey</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>JH</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Eur Cytokine Netw</source>
            <pubdate>1993</pubdate>
            <volume>4</volume>
            <fpage>15</fpage>
            <lpage>23</lpage>
            <xrefbib>
               <pubid idtype="pmpid">8490101</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B18">
            <title>
               <p>Role of the CD40-CD40 ligand interaction in CD4<sup>+ </sup>T cell contact-dependent activation of monocyte interleukin-1 synthesis</p>
            </title>
            <aug>
               <au>
                  <snm>Wagner</snm>
                  <fnm>DH</fnm>
                  <suf>Jr</suf>
               </au>
               <au>
                  <snm>Stout</snm>
                  <fnm>RD</fnm>
               </au>
               <au>
                  <snm>Suttles</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1994</pubdate>
            <volume>24</volume>
            <fpage>3148</fpage>
            <lpage>3154</lpage>
            <xrefbib>
               <pubid idtype="pmpid">7528671</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B19">
            <title>
               <p>Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of TNF&#945; but not IL-10: possible relevance to pathophysiology of rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Sebbag</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Parry</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1997</pubdate>
            <volume>27</volume>
            <fpage>624</fpage>
            <lpage>632</lpage>
            <xrefbib>
               <pubid idtype="pmpid">9079801</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B20">
            <title>
               <p>Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction</p>
            </title>
            <aug>
               <au>
                  <snm>Shu</snm>
                  <fnm>U</fnm>
               </au>
               <au>
                  <snm>Kiniwa</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Wu</snm>
                  <fnm>CY</fnm>
               </au>
               <au>
                  <snm>Maliszewski</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Vezzio</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Hakimi</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Gately</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Delespesse</snm>
                  <fnm>G</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1995</pubdate>
            <volume>25</volume>
            <fpage>1125</fpage>
            <lpage>1128</lpage>
            <xrefbib>
               <pubid idtype="pmpid">7537673</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B21">
            <title>
               <p>Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF&#945;</p>
            </title>
            <aug>
               <au>
                  <snm>Parry</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Sebbag</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1997</pubdate>
            <volume>158</volume>
            <fpage>3673</fpage>
            <lpage>3681</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmpid" link="fulltext">9103430</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B22">
            <title>
               <p>An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies</p>
            </title>
            <aug>
               <au>
                  <snm>Duke</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Panayi</snm>
                  <fnm>GS</fnm>
               </au>
               <au>
                  <snm>Janossy</snm>
                  <fnm>G</fnm>
               </au>
               <au>
                  <snm>Poulter</snm>
                  <fnm>LW</fnm>
               </au>
            </aug>
            <source>Clin Exp Immunol</source>
            <pubdate>1982</pubdate>
            <volume>49</volume>
            <fpage>22</fpage>
            <lpage>30</lpage>
            <xrefbib>
               <pubid idtype="pmpid">6751631</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B23">
            <title>
               <p>Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells</p>
            </title>
            <aug>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Hayes</snm>
                  <fnm>AL</fnm>
               </au>
               <au>
                  <snm>Ciesielski</snm>
                  <fnm>CJ</fnm>
               </au>
               <au>
                  <snm>Green</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2002</pubdate>
            <volume>46</volume>
            <fpage>31</fpage>
            <lpage>41</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/1529-0131(200201)46:1&lt;31::AID-ART10029>3.0.CO;2-5</pubid>
                  <pubid idtype="pmpid">11822409</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B24">
            <title>
               <p>Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-&#954;B dependent</p>
            </title>
            <aug>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Browne</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Bondeson</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Clarke</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>de Martin</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Proc Natl Acad Sci USA</source>
            <pubdate>1998</pubdate>
            <volume>95</volume>
            <fpage>8211</fpage>
            <lpage>8215</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">20955</pubid>
                  <pubid idtype="pmpid" link="fulltext">9653166</pubid>
                  <pubid idtype="doi">10.1073/pnas.95.14.8211</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B25">
            <title>
               <p>Heterogeneous requirement of I&#954;B kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy</p>
            </title>
            <aug>
               <au>
                  <snm>Andreakos</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Smith</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Kiriakidis</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Monaco</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>de Martin</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Paleolog</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2003</pubdate>
            <volume>48</volume>
            <fpage>1901</fpage>
            <lpage>1912</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.11044</pubid>
                  <pubid idtype="pmpid" link="fulltext">12847684</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B26">
            <title>
               <p>Inhibition of endothelial cell activation by adenovirus-mediated expression of I&#954;B&#945;, an inhibitor of the transcription factor NF-&#954;B</p>
            </title>
            <aug>
               <au>
                  <snm>Wrighton</snm>
                  <fnm>CJ</fnm>
               </au>
               <au>
                  <snm>Hofer-Warbinek</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Moll</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Eytner</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Bach</snm>
                  <fnm>FH</fnm>
               </au>
               <au>
                  <snm>de Martin</snm>
                  <fnm>R</fnm>
               </au>
            </aug>
            <source>J Exp Med</source>
            <pubdate>1996</pubdate>
            <volume>183</volume>
            <fpage>1013</fpage>
            <lpage>1022</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1084/jem.183.3.1013</pubid>
                  <pubid idtype="pmpid" link="fulltext">8642242</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B27">
            <title>
               <p>Methods for construction of adenovirus vectors</p>
            </title>
            <aug>
               <au>
                  <snm>Graham</snm>
                  <fnm>FL</fnm>
               </au>
               <au>
                  <snm>Prevec</snm>
                  <fnm>L</fnm>
               </au>
            </aug>
            <source>Mol Biotechnol</source>
            <pubdate>1995</pubdate>
            <volume>3</volume>
            <fpage>207</fpage>
            <lpage>220</lpage>
            <xrefbib>
               <pubid idtype="pmpid">7552690</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B28">
            <title>
               <p>Selective regulation of cytokine induction by adenoviral gene transfer of I&#954;B&#945; into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-&#954;B independent</p>
            </title>
            <aug>
               <au>
                  <snm>Bondeson</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Browne</snm>
                  <fnm>KA</fnm>
               </au>
               <au>
                  <snm>Brennan</snm>
                  <fnm>FM</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1999</pubdate>
            <volume>162</volume>
            <fpage>2939</fpage>
            <lpage>2945</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmpid" link="fulltext">10072544</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B29">
            <title>
               <p>NF-&#954;B induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis</p>
            </title>
            <aug>
               <au>
                  <snm>Wang</snm>
                  <fnm>CY</fnm>
               </au>
               <au>
                  <snm>Guttridge</snm>
                  <fnm>DC</fnm>
               </au>
               <au>
                  <snm>Mayo</snm>
                  <fnm>MW</fnm>
               </au>
               <au>
                  <snm>Baldwin</snm>
                  <fnm>AS</fnm>
                  <suf>Jr</suf>
               </au>
            </aug>
            <source>Mol Cell Biol</source>
            <pubdate>1999</pubdate>
            <volume>19</volume>
            <fpage>5923</fpage>
            <lpage>5929</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">84448</pubid>
                  <pubid idtype="pmpid" link="fulltext">10454539</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B30">
            <title>
               <p>TNF&#945;-induced macrophage chemokine secretion is more dependent on NF-&#954;B expression than lipopolysaccharides-induced macrophage chemokine secretion</p>
            </title>
            <aug>
               <au>
                  <snm>Ciesielski</snm>
                  <fnm>CJ</fnm>
               </au>
               <au>
                  <snm>Andreakos</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>2002</pubdate>
            <volume>32</volume>
            <fpage>2037</fpage>
            <lpage>2045</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/1521-4141(200207)32:7&lt;2037::AID-IMMU2037>3.0.CO;2-I</pubid>
                  <pubid idtype="pmpid" link="fulltext">12115625</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B31">
            <title>
               <p>Nuclear factor-&#954;B: a pivotal transcription factor in chronic inflammatory diseases</p>
            </title>
            <aug>
               <au>
                  <snm>Barnes</snm>
                  <fnm>PJ</fnm>
               </au>
               <au>
                  <snm>Karin</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>N Engl J Med</source>
            <pubdate>1997</pubdate>
            <volume>336</volume>
            <fpage>1066</fpage>
            <lpage>1071</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1056/NEJM199704103361506</pubid>
                  <pubid idtype="pmpid" link="fulltext">9091804</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B32">
            <title>
               <p>Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines</p>
            </title>
            <aug>
               <au>
                  <snm>Burger</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Rezzonico</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Li</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Modoux</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Pierce</snm>
                  <fnm>RA</fnm>
               </au>
               <au>
                  <snm>Welgus</snm>
                  <fnm>HG</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>1998</pubdate>
            <volume>41</volume>
            <fpage>1748</fpage>
            <lpage>1759</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/1529-0131(199810)41:10&lt;1748::AID-ART7>3.0.CO;2-3</pubid>
                  <pubid idtype="pmpid">9778216</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B33">
            <title>
               <p>The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction</p>
            </title>
            <aug>
               <au>
                  <snm>Burger</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Arthritis Res</source>
            <pubdate>2002</pubdate>
            <volume>4</volume>
            <issue>Suppl 3</issue>
            <fpage>S169</fpage>
            <lpage>S176</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1186/ar558</pubid>
                  <pubid idtype="pmpid" link="fulltext">12110136</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B34">
            <title>
               <p>Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals</p>
            </title>
            <aug>
               <au>
                  <snm>Landis</snm>
                  <fnm>RC</fnm>
               </au>
               <au>
                  <snm>Friedman</snm>
                  <fnm>ML</fnm>
               </au>
               <au>
                  <snm>Fisher</snm>
                  <fnm>RI</fnm>
               </au>
               <au>
                  <snm>Ellis</snm>
                  <fnm>TM</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1991</pubdate>
            <volume>146</volume>
            <fpage>128</fpage>
            <lpage>135</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">1824588</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B35">
            <title>
               <p>IFN-&#947; and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells</p>
            </title>
            <aug>
               <au>
                  <snm>Vey</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Zhang</snm>
                  <fnm>JH</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1992</pubdate>
            <volume>149</volume>
            <fpage>2040</fpage>
            <lpage>2046</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">1517568</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B36">
            <title>
               <p>Expression and cleavage of tumor necrosis factor-&#945; and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells</p>
            </title>
            <aug>
               <au>
                  <snm>Vey</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Burger</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1996</pubdate>
            <volume>26</volume>
            <fpage>2404</fpage>
            <lpage>2409</lpage>
            <xrefbib>
               <pubid idtype="pmpid">8898953</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B37">
            <title>
               <p>T cell induction of membrane IL 1 on macrophages</p>
            </title>
            <aug>
               <au>
                  <snm>Weaver</snm>
                  <fnm>CT</fnm>
               </au>
               <au>
                  <snm>Unanue</snm>
                  <fnm>ER</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1986</pubdate>
            <volume>137</volume>
            <fpage>3868</fpage>
            <lpage>3873</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">2946770</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B38">
            <title>
               <p>T cell induction of macrophage IL-1 during antigen presentation. Characterization of a lymphokine mediator and comparison of TH1 and TH2 subsets</p>
            </title>
            <aug>
               <au>
                  <snm>Weaver</snm>
                  <fnm>CT</fnm>
               </au>
               <au>
                  <snm>Duncan</snm>
                  <fnm>LM</fnm>
               </au>
               <au>
                  <snm>Unanue</snm>
                  <fnm>ER</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1989</pubdate>
            <volume>142</volume>
            <fpage>3469</fpage>
            <lpage>3476</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">2523927</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B39">
            <title>
               <p>Human Th1 cells preferentially induce interleukin (IL)-1&#946; while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes</p>
            </title>
            <aug>
               <au>
                  <snm>Chizzolini</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Chicheportiche</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Burger</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Dayer</snm>
                  <fnm>JM</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1997</pubdate>
            <volume>27</volume>
            <fpage>171</fpage>
            <lpage>177</lpage>
            <xrefbib>
               <pubid idtype="pmpid">9022014</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B40">
            <title>
               <p>The toll-like receptor-nuclear factor &#954;B pathway in rheumatoid arthritis</p>
            </title>
            <aug>
               <au>
                  <snm>Andreakos</snm>
                  <fnm>E</fnm>
               </au>
               <au>
                  <snm>Sacre</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Foxwell</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Feldmann</snm>
                  <fnm>M</fnm>
               </au>
            </aug>
            <source>Front Biosci</source>
            <pubdate>2005</pubdate>
            <volume>10</volume>
            <fpage>2478</fpage>
            <lpage>2488</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">15970510</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B41">
            <title>
               <p>Cooperative interaction of nuclear factor-&#954;B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines</p>
            </title>
            <aug>
               <au>
                  <snm>Mukaida</snm>
                  <fnm>N</fnm>
               </au>
               <au>
                  <snm>Mahe</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Matsushima</snm>
                  <fnm>K</fnm>
               </au>
            </aug>
            <source>J Biol Chem</source>
            <pubdate>1990</pubdate>
            <volume>265</volume>
            <fpage>21128</fpage>
            <lpage>21133</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">2250017</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B42">
            <title>
               <p>Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-&#954;B and novel constitutive factors</p>
            </title>
            <aug>
               <au>
                  <snm>Wood</snm>
                  <fnm>LD</fnm>
               </au>
               <au>
                  <snm>Richmond</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>J Biol Chem</source>
            <pubdate>1995</pubdate>
            <volume>270</volume>
            <fpage>30619</fpage>
            <lpage>30626</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1074/jbc.270.51.30619</pubid>
                  <pubid idtype="pmpid" link="fulltext">8530498</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B43">
            <title>
               <p>RelB regulation of chemokine expression modulates local inflammation</p>
            </title>
            <aug>
               <au>
                  <snm>Xia</snm>
                  <fnm>Y</fnm>
               </au>
               <au>
                  <snm>Pauza</snm>
                  <fnm>ME</fnm>
               </au>
               <au>
                  <snm>Feng</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Lo</snm>
                  <fnm>D</fnm>
               </au>
            </aug>
            <source>Am J Pathol</source>
            <pubdate>1997</pubdate>
            <volume>151</volume>
            <fpage>375</fpage>
            <lpage>387</lpage>
            <xrefbib>
               <pubid idtype="pmpid">9250151</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B44">
            <title>
               <p>Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-&#954;B and AP-1</p>
            </title>
            <aug>
               <au>
                  <snm>Martin</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Cardarelli</snm>
                  <fnm>PM</fnm>
               </au>
               <au>
                  <snm>Parry</snm>
                  <fnm>GC</fnm>
               </au>
               <au>
                  <snm>Felts</snm>
                  <fnm>KA</fnm>
               </au>
               <au>
                  <snm>Cobb</snm>
                  <fnm>RR</fnm>
               </au>
            </aug>
            <source>Eur J Immunol</source>
            <pubdate>1997</pubdate>
            <volume>27</volume>
            <fpage>1091</fpage>
            <lpage>1097</lpage>
            <xrefbib>
               <pubid idtype="pmpid">9174597</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B45">
            <title>
               <p>Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-&#954;B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of &#954;B&#945;</p>
            </title>
            <aug>
               <au>
                  <snm>Thomas</snm>
                  <fnm>LH</fnm>
               </au>
               <au>
                  <snm>Friedland</snm>
                  <fnm>JS</fnm>
               </au>
               <au>
                  <snm>Sharland</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Becker</snm>
                  <fnm>S</fnm>
               </au>
            </aug>
            <source>J Immunol</source>
            <pubdate>1998</pubdate>
            <volume>161</volume>
            <fpage>1007</fpage>
            <lpage>1016</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">9670982</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B46">
            <title>
               <p>The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-&#945; gene transcription</p>
            </title>
            <aug>
               <au>
                  <snm>McCaffrey</snm>
                  <fnm>PG</fnm>
               </au>
               <au>
                  <snm>Goldfeld</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Rao</snm>
                  <fnm>A</fnm>
               </au>
            </aug>
            <source>J Biol Chem</source>
            <pubdate>1994</pubdate>
            <volume>269</volume>
            <fpage>30445</fpage>
            <lpage>30450</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">7982959</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B47">
            <title>
               <p>One nucleotide in a &#954;B site can determine cofactor specificity for NF-&#954;B dimers</p>
            </title>
            <aug>
               <au>
                  <snm>Leung</snm>
                  <fnm>TH</fnm>
               </au>
               <au>
                  <snm>Hoffmann</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Baltimore</snm>
                  <fnm>D</fnm>
               </au>
            </aug>
            <source>Cell</source>
            <pubdate>2004</pubdate>
            <volume>118</volume>
            <fpage>453</fpage>
            <lpage>464</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.cell.2004.08.007</pubid>
                  <pubid idtype="pmpid" link="fulltext">15315758</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B48">
            <title>
               <p>How important are T cells in chronic rheumatoid synovitis?</p>
            </title>
            <aug>
               <au>
                  <snm>Firestein</snm>
                  <fnm>GS</fnm>
               </au>
               <au>
                  <snm>Zvaifler</snm>
                  <fnm>NJ</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>1990</pubdate>
            <volume>33</volume>
            <fpage>768</fpage>
            <lpage>773</lpage>
            <xrefbib>
               <pubid idtype="pmpid">2194461</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B49">
            <title>
               <p>How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end</p>
            </title>
            <aug>
               <au>
                  <snm>Firestein</snm>
                  <fnm>GS</fnm>
               </au>
               <au>
                  <snm>Zvaifler</snm>
                  <fnm>NJ</fnm>
               </au>
            </aug>
            <source>Arthritis Rheum</source>
            <pubdate>2002</pubdate>
            <volume>46</volume>
            <fpage>298</fpage>
            <lpage>308</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1002/art.502</pubid>
                  <pubid idtype="pmpid" link="fulltext">11840432</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
